93
|
TargetMol
antagonist dy268 Antagonist Dy268, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/antagonist dy268/product/TargetMol Average 93 stars, based on 1 article reviews
antagonist dy268 - by Bioz Stars,
2026-05
93/100 stars
|
Buy from Supplier |
94
|
Tocris
dy268 Dy268, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/dy268/product/Tocris Average 94 stars, based on 1 article reviews
dy268 - by Bioz Stars,
2026-05
94/100 stars
|
Buy from Supplier |
90
|
Axon Medchem LLC
dy-268 2561 Dy 268 2561, supplied by Axon Medchem LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/dy-268 2561/product/Axon Medchem LLC Average 90 stars, based on 1 article reviews
dy-268 2561 - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
N/A
|
DY 268 is a farnesoid X receptor FXR antagonist IC 7 5 nM in a time resolved FRET assay It inhibits FXR transactivation in a cell based assay with an IC value of 468 nM
|
Buy from Supplier |
N/A
|
Product descriptionDY268 is a farnesoid X receptor (FXR) antagonist (IC50=7.5 nM in a time-resolved FRET assay). It inhibits FXR transactivation in a cell-based assay with an IC50 value of 468 nM.
|
Buy from Supplier |
N/A
|
DY-268, a pyrazol carboamide derivative, has been found to be a FXR antagonist that could be significant in studies of the biological activities of FXR. IC50: 7.5 nM.
|
Buy from Supplier |